| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $127.8M | $141.9M | $151.9M |
| YoY Revenue Growth % | -9.9% | -6.6% | — |
| Gross Profit | $108.2M | $121.7M | — |
| Gross Margin % | 84.7% | 85.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$11.4M | $6.3M | $6.3M |
| Operating Margin % | -8.9% | 4.5% | 4.1% |
| Net Income (GAAP) | -$13.5M | $253.0K | $3.5M |
| EBITDA (Normalized) | -$5.5M | $17.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $21.1M | $21.0M | $21.3M |
| Capital Expenditures (CapEx) | $7.3M | $13.9M | — |
| Free Cash Flow (FCF) | $13.8M | $7.1M | $21.3M |
| FCF Margin % | 10.8% | 5.0% | 14.1% |
| Return on Invested Capital (ROIC %) | -7.4% | 3.5% | — |
| Cash & Short-Term Equivalents | $2.9M | $3.7M | — |
| Total Debt (Short + Long Term) | $30.0M | $32.0M | — |
| Total Stockholders' Equity | $94.5M | $114.3M | — |